Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$109,148
+$28,209 QoQ
Shares Held
91
+3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#4,482
of 4,605 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Imprint Wealth LLC holds $212,027 across 8 Drug Manufacturers - General names. LLY ranks #1 (51.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
91 | $109,148 | |
| 2 | JNJ |
Johnson & Johnson
|
195 | $49,524 | |
| 3 | NVS |
Novartis AG
|
150 | $23,508 | |
| 4 | ABBV |
AbbVie Inc.
|
39 | $9,813 | |
| 5 | MRK |
Merck & Co., Inc.
|
48 | $6,168 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
45 | $5,685 | |
| 7 | AZN |
Astrazeneca PLC
|
22 | $4,171 | |
| 8 | SNY |
Sanofi
|
94 | $4,010 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,148 | 91 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $80,939 | 88 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $113,916 | 106 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $141,918 | 186 | Shares | Sole | 2025-11-14 | |
| 2024-03-31 | $3,326,556 | 4,276 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $801,515 | 1,375 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $1,463,142 | 2,724 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,669,099 | 3,559 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $1,117,488 | 3,254 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||